Suppr超能文献

胸腔镜肺叶切除术治疗 80 岁以上非小细胞肺癌患者的术后结果和生活质量评估:来自国家数据库的分析。

Post-operative outcomes and quality of life assessment after thoracoscopic lobectomy for Non-small-cell lung cancer in octogenarians: Analysis from a national database.

机构信息

Thoracic Surgery Unit, Careggi University Hospital, Florence, Italy.

Thoracic Surgery Unit, Careggi University Hospital, Florence, Italy.

出版信息

Surg Oncol. 2021 Jun;37:101530. doi: 10.1016/j.suronc.2021.101530. Epub 2021 Feb 1.

Abstract

BACKGROUND

Thoracoscopic lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) is a well-established option for early stage NSCLC, but the evidences are limited for octogenarians.

OBJECTIVE

The objectives of this multi-institutional study were to evaluate the post-operative outcomes of VATS-L in octogenarians and to estimate the post-operative quality of life (QoL) using a validated questionnaire (EuroQoL5D).

METHODS

Data from patients underwent VATS-L between 2014 and 2019 were analysed and divided into two groups: Group A (younger patients) and Group B (octogenarians). To define predictors for complications, univariate and multivariable logistic regression analysis were performed.

RESULTS

7023 patients underwent VATS-L and 329 (4.6%) were octogenarians. 30-day and 90-day post-operative mortality were similar (0.95% vs 0.91%, p = 0.84 and 1.3% vs 1.2%, p = 0.58), whereas the percentage of patients who suffered from any complication (25.5% vs 31.9%, p = 0.012) and the complication rate (31.6% vs 45.2%, p=<0.01) were higher for octogenarians. At discharge, the values of EuroQoL5D were worse in group B, but after one month these levels became similar. Age >80 years had a significant influence on morbidity on both univariate and multivariable analyses (p = 0.025).

CONCLUSIONS

VATS-L for NSCLC can be performed in selected octogenarians without increased risk of post-operative death, acceptable not-life-threatening complications and a moderate impact on QoL.

摘要

背景

胸腔镜肺叶切除术(VATS-L)是治疗非小细胞肺癌(NSCLC)的一种成熟选择,尤其适用于早期 NSCLC 患者,但高龄患者的相关证据有限。

目的

本多中心研究旨在评估 VATS-L 在 80 岁以上患者中的术后效果,并使用经过验证的问卷(EuroQoL5D)评估术后生活质量(QoL)。

方法

分析了 2014 年至 2019 年间接受 VATS-L 治疗的患者数据,并将其分为两组:A 组(年轻患者)和 B 组(80 岁以上患者)。为了确定并发症的预测因素,进行了单变量和多变量逻辑回归分析。

结果

7023 例患者接受了 VATS-L 治疗,其中 329 例(4.6%)为 80 岁以上患者。30 天和 90 天的术后死亡率相似(0.95% vs 0.91%,p=0.84 和 1.3% vs 1.2%,p=0.58),但 80 岁以上患者发生任何并发症(25.5% vs 31.9%,p=0.012)和并发症发生率(31.6% vs 45.2%,p<0.01)更高。出院时,B 组的 EuroQoL5D 值较低,但一个月后这些值变得相似。年龄>80 岁在单变量和多变量分析中对发病率均有显著影响(p=0.025)。

结论

在选择合适的 80 岁以上患者中,VATS-L 治疗 NSCLC 不会增加术后死亡风险,可接受的非危及生命的并发症发生率和对 QoL 的中度影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验